Antigenic diversity and cross-reactivity of avian influenza H5N1 viruses in Egypt between 2006 and 2011

Journal of General Virology

Volumn 93, Issue PART 12, 2012, Pages 2564-2574

  El Shesheny, Rabeh ^a   Kayali, Ghazi ^b   Kandeil, Ahmed ^a   Cai, Zhipeng ^c   Barakat, Ahmed B ^d   Ghanim, Hossam ^d   Ali, Mohamed A ^a  

^a NATIONAL RESEARCH CENTRE   (Egypt)

^b ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^c GEORGIA STATE UNIVERSITY   (United States)

^d Ain Shams University   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODIES,ANTISERA AND IMMUNOGLOBULINS; AVIAN INFLUENZA VACCINE; CROSS REACTING ANTIGEN; HN PROTEIN; INACTIVATED VIRUS VACCINE; MONOCLONAL ANTIBODY; POLYCLONAL ANTIBODY; SIALIDASE; VIRUS ANTIBODY;

ANTIGENIC VARIATION; ARTICLE; AVIAN INFLUENZA VIRUS; CONTROLLED STUDY; CROSS REACTION; EGYPT; HEMAGGLUTINATION; IMMUNIZATION; INFLUENZA VIRUS A H5N1; MICROBIAL DIVERSITY; NONHUMAN; NUCLEOTIDE SEQUENCE; POULTRY; PRIORITY JOURNAL; PUERTO RICO; RAT; REVERSE GENETICS; VIET NAM; VIRUS ISOLATION;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODIES, VIRAL; ANTIGENIC VARIATION; ANTIGENS, VIRAL; CROSS REACTIONS; EGYPT; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; INFLUENZA A VIRUS, H5N1 SUBTYPE; INFLUENZA IN BIRDS; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; PHYLOGENY; POULTRY; RATS; SEQUENCE HOMOLOGY, AMINO ACID;

AVES; ORTHOMYXOVIRIDAE; RATTUS;

EID: 84869232610     PISSN: 00221317     EISSN: 14652099     Source Type: Journal    
DOI: 10.1099/vir.0.043299-0     Document Type: Article

References (52)

1. Abdel-Moneim, A. S., Shany, S. A., Fereidouni, S. R., Eid, B. T., el-Kady, M. F., Starick, E., Harder, T. & Keil, G. M. (2009). Sequence diversity of the haemagglutinin open reading frame of recent highly pathogenic avian influenza H5N1 isolates from Egypt. Arch Virol 154, 1559-1562.
2. Abdelwhab, E. M. & Hafez, H. M. (2011). An overview of the epidemic of highly pathogenic H5N1 avian influenza virus in Egypt: epidemiology and control challenges. Epidemiol Infect 139, 647-657.
3. Abdelwhab, S. M., Arafa, A. S., Erfan, A. M., Aly, M. M. & Hafez, H. M. (2010a). Modified H5 real-time reverse transcriptase-PCR oligonucleotides for detection of divergent avian influenza H5N1 viruses in Egypt. Avian Dis 54, 1301-1305.
4. Abdelwhab, S. M., Erfan, A.M., Grund, C., Ziller, M., Arafa, A. S., Beer, M., Aly, M. M., Hafez, H. M. & Harder, T. C. (2010b). Simultaneous detection and differentiation by multiplex real time RT-PCR of highly pathogenic avian influenza subtype H5N1 classic (clade 2.2.1 proper) and escape mutant (clade 2.2.1 variant) lineages in Egypt. Virol J 7, 260.
5. Abdelwhab, E. M., Grund, C., Aly, M. M., Beer, M., Harder, T. C. & Hafez, H. M. (2012). Influence of maternal immunity on vaccine efficacy and susceptibility of one day old chicks against Egyptian highly pathogenic avian influenza H5N1. Vet Microbiol 155, 13-20.
6. Aly, M. M., Arafa, A. & Hassan, M. K. (2008). Epidemiological findings of outbreaks of disease caused by highly pathogenic H5N1 avian influenza virus in poultry in Egypt during 2006. Avian Dis 52, 269-277.
7. Arafa, A., Suarez, D. L., Hassan, M. K. & Aly, M. M. (2010). Phylogenetic analysis of hemagglutinin and neuraminidase genes of highly pathogenic avian influenza H5N1 Egyptian strains isolated from 2006 to 2008 indicates heterogeneity with multiple distinct sublineages. Avian Dis 54 (Suppl.), 345-349.
8. Balish, A. L., Davis, C. T., Saad, M. D., El-Sayed, N., Esmat, H., Tjaden, J. A., Earhart, K. C., Ahmed, L. E., Abd El-Halem, M. & other authors (2010). Antigenic and genetic diversity of highly pathogenic avian influenza A (H5N1) viruses isolated in Egypt. Avian Dis 54 (Suppl.), 329-334.
9. Baras, B., Stittelaar, K. J., Simon, J. H., Thoolen, R. J., Mossman, S. P., Pistoor, F. H., van Amerongen, G., Wettendorff, M. A., Hanon, E. & Osterhaus, A. D. (2008). Cross-protection against lethal H5N1 challenge in ferrets with an adjuvanted pandemic influenza vaccine. PLoS ONE 3, e1401.
10. Boon, A. C. & Webby, R. J. (2009). Antigenic cross-reactivity among H5N1 viruses. Curr Top Microbiol Immunol 333, 25-40.
11. Cai, Z., Zhang, T. & Wan, X. F. (2010). A computational framework for influenza antigenic cartography. PLOS Comput Biol 6, e1000949.
12. Carrat, F. & Flahault, A. (2007). Influenza vaccine: the challenge of antigenic drift. Vaccine 25, 6852-6862.
13. Cattoli, G., Fusaro, A., Monne, I., Coven, F., Joannis, T., El-Hamid, H. S., Hussein, A. A., Cornelius, C., Amarin, N. M. & other authors (2011). Evidence for differing evolutionary dynamics of A/H5N1 viruses among countries applying or not applying avian influenza vaccination in poultry. Vaccine 29, 9368-9375.
14. Chen, H., Smith, G. J., Li, K. S., Wang, J., Fan, X. H., Rayner, J. M., Vijaykrishna, D., Zhang, J. X., Zhang, L. J. & other authors (2006). Establishment of multiple sublineages of H5N1 influenza virus in Asia: implications for pandemic control. Proc Natl Acad Sci U S A 103, 2845-2850.
15. Chenna, R., Sugawara, H., Koike, T., Lopez, R., Gibson, T. J., Higgins, D. G. & Thompson, J. D. (2003). Multiple sequence alignment with the CLUSTAL series of programs. Nucleic Acids Res 31, 3497-3500.
16. Claas, E. C., Osterhaus, A. D., van Beek, R., De Jong, J. C., Rimmelzwaan, G. F., Senne, D. A., Krauss, S., Shortridge, K. F. & Webster, R. G. (1998). Human influenza A H5N1 virus related to a highly pathogenic avian influenza virus. Lancet 351, 472-477.
17. De Vriese, J., Steensels, M., Palya, V., Gardin, Y., Dorsey, K. M., Lambrecht, B., Van Borm, S. & van den Berg, T. (2010). Passive protection afforded bymaternally-derived antibodies in chickens and the antibodies' interference with the protection elicited by avian influenzainactivated vaccines in progeny. Avian Dis 54 (Suppl.), 246-252.
18. Ducatez, M. F., Cai, Z., Peiris, M., Guan, Y., Ye, Z., Wan, X. F. & Webby, R. J. (2011). Extent of antigenic cross-reactivity among highly pathogenic H5N1 influenza viruses. J Clin Microbiol 49, 3531-3536.
19. Eladl, A. E., El-Azm, K. I., Ismail, A. E., Ali, A., Saif, Y. M. & Lee, C. W. (2011). Genetic characterization of highly pathogenic H5N1 avian influenza viruses isolated from poultry farms in Egypt. Virus Genes 43, 272-280.
20. Escorcia, M., Vázquez, L., Méndez, S. T., Rodríguez-Ropó n, A., Lucio, E. & Nava, G. M. (2008). Avian influenza: genetic evolution under vaccination pressure. Virol J 5, 15.
21. Govorkova, E. A., Webby, R. J., Humberd, J., Seiler, J. P. & Webster, R. G. (2006). Immunization with reverse-genetics-produced H5N1 influenza vaccine protects ferrets against homologous and heterologous challenge. J Infect Dis 194, 159-167.
22. Grund, C., Abdelwhab, S. M., Arafa, A. S., Ziller, M., Hassan, M. K., Aly, M. M., Hafez, H. M., Harder, T. C. & Beer, M. (2011). Highly pathogenic avian influenza virus H5N1 from Egypt escapes vaccineinduced immunity but confers clinical protection against a heterologous clade 2.2.1 Egyptian isolate. Vaccine 29, 5567-5573.
23. Guan, Y., Poon, L. L., Cheung, C. Y., Ellis, T. M., Lim, W., Lipatov, A. S., Chan, K. H., Sturm-Ramirez, K. M., Cheung, C. L. & other authors (2004). H5N1 influenza: a protean pandemic threat. Proc Natl Acad Sci U S A 101, 8156-8161.
24. Hafez, M. H., Arafa, A., Abdelwhab, E. M., Selim, A., Khoulosy, S. G., Hassan, M. K. & Aly, M. M. (2010). Avian influenza H5N1 virus infections in vaccinated commercial and backyard poultry in Egypt. Poult Sci 89, 1609-1613.
25. Hall, T. A. (1999). BioEdit: a user-friendly biological sequence alignment editor and analysis program for Windows 95/98/NT. Nucleic Acids Symp Ser 41, 95-98.
26. Hanson, B. J., Boon, A. C., Lim, A. P., Webb, A., Ooi, E. E. & Webby, R. J. (2006). Passive immunoprophylaxis and therapy with humanized monoclonal antibody specific for influenza A H5 hemagglutinin in mice. Respir Res 7, 126.
27. Hassan, M. K., Kilany, W. H., Abdelwhab, E. M., Arafa, A. S., Selim, A., Samy, A., Samir, M., Le Brun, Y., Jobre, Y. & Aly, M. M. (2012). Distribution of avian influenza H5N1 viral RNA in tissues of AIvaccinated and unvaccinated contact chickens after experimental infection. Arch Virol 157, 951-959.
28. Kaverin, N. V., Rudneva, I. A., Govorkova, E. A., Timofeeva, T. A., Shilov, A. A., Kochergin-Nikitsky, K. S., Krylov, P. S. & Webster, R. G. (2007). Epitope mapping of the hemagglutinin molecule of a highly pathogenic H5N1 influenza virus by using monoclonal antibodies. J Virol 81, 12911-12917.
29. Kayali, G., El-Shesheny, R., Kutkat, M. A., Kandeil, A. M., Mostafa, A., Ducatez, M. F., McKenzie, P. P., Govorkova, E. A., Nasraa, M. H. & other authors (2011a). Continuing threat of influenza (H5N1) virus circulation in Egypt. Emerg Infect Dis 17, 2306-2308.
30. Kayali, G., Webby, R. J., Ducatez, M. F., El Shesheny, R. A., Kandeil, A. M., Govorkova, E. A., Mostafa, A. & Ali, M. A. (2011b). The epidemiological and molecular aspects of influenza H5N1 viruses at the human-animal interface in Egypt. PLoS ONE 6, e17730.
31. Kim, J. K., Kayali, G., Walker, D., Forrest, H. L., Ellebedy, A. H., Griffin, Y. S., Rubrum, A., Bahgat, M. M., Kutkat, M. A. & other authors (2010). Puzzling inefficiency of H5N1 influenza vaccines in Egyptian poultry. Proc Natl Acad Sci U S A 107, 11044-11049.
32. Lee, C. W., Senne, D. A. & Suarez, D. L. (2004). Effect of vaccine use in the evolution of Mexican lineage H5N2 avian influenza virus. J Virol 78, 8372-8381.
33. Peyre, M., Samaha, H., Makonnen, Y. J., Saad, A., Abd-Elnabi, A., Galal, S., Ettel, T., Dauphin, G., Lubroth, J. & other authors (2009). Avian influenza vaccination in Egypt: limitations of the current strategy. J Mol Genet Med 3, 198-204.
34. Plotkin, J. B. & Dushoff, J. (2003). Codon bias and frequencydependent selection on the hemagglutinin epitopes of influenza A virus. Proc Natl Acad Sci U S A 100, 7152-7157.
35. Rauw, F., Palya, V., Van Borm, S., Welby, S., Tatar-Kis, T., Gardin, Y., Dorsey, K. M., Aly, M. M., Hassan, M. K. & other authors (2011). Further evidence of antigenic drift and protective efficacy afforded by a recombinant HVT-H5 vaccine against challenge with two antigenically divergent Egyptian clade 2.2.1 HPAI H5N1 strains. Vaccine 29, 2590-2600.
36. Saad, M. D., Ahmed, L. S., Gamal-Eldein, M. A., Fouda, M. K., Khalil, F., Yingst, S. L., Parker, M. A. & Montevillel, M. R. (2007). Possible avian influenza (H5N1) from migratory bird, Egypt. Emerg Infect Dis 13, 1120-1121.
37. Swayne, D. E. (2006). Recommendations from the avian influenza vaccine workshop. Ann N Y Acad Sci 1081, 226-227.
38. Swayne, D. E. (2009). Avian influenza vaccines and therapies for poultry. Comp Immunol Microbiol Infect Dis 32, 351-363.
39. Swayne, D. E. & Kapczynski, D. (2008). Strategies and challenges for eliciting immunity against avian influenza virus in birds. Immunol Rev 225, 314-331.
40. Tamura, K., Dudley, J., Nei, M. & Kumar, S. (2007). MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0. Mol Biol Evol 24, 1596-1599.
41. Wang, H. & Jiang, C. (2009). Avian influenza H5N1: an update on molecular pathogenesis. Sci China Series C. Life Sci 52, 459-463.
42. Watanabe, Y., Ibrahim, M. S., Ellakany, H. F., Kawashita, N., Mizuike, R., Hiramatsu, H., Sriwilaijaroen, N., Takagi, T., Suzuki, Y. & Ikuta, K. (2011). Acquisition of human-type receptor binding specificity by new H5N1 influenza virus sublineages during their emergence in birds in Egypt. PLoS Pathog 7, e1002068.
43. Watanabe, Y., Ibrahim, M. S., Ellakany, H. F., Kawashita, N., Daidoji, T., Takagi, T., Yasunaga, T., Nakaya, T. & Ikuta, K. (2012). Antigenic analysis of highly pathogenic avian influenza virus H5N1 sublineages co-circulating in Egypt. J Gen Virol 93, 2215-2226.
44. Webby, R. J., Perez, D. R., Coleman, J. S., Guan, Y., Knight, J. H., Govorkova, E. A., McClain-Moss, L. R., Peiris, J. S., Rehg, J. E. & other authors (2004). Responsiveness to a pandemic alert: use of reverse genetics for rapid development of influenza vaccines. Lancet 363, 1099-1103.
45. Webster, R. G. (2002). The importance of animal influenza for human disease. Vaccine 20 (Suppl. 2), S16-S20.
46. Webster, R. G., Bean, W. J., Gorman, O. T., Chambers, T. M. & Kawaoka, Y. (1992). Evolution and ecology of influenza A viruses. Microbiol Rev 56, 152-179.
47. WHO (2002). WHO Manual on Animal Influenza Diagnosis and Surveillance, 2nd edn. Geneva, Switzerland: World Health Organization.
48. WHO (2009). WHO Information for Laboratory Diagnosis of New Influenza A (H1N1) Virus in Humans, 21 May 2009. Geneva, Switzerland: World Health Organization.
49. WHO/OIE/FAO (2009). Continuing progress towards a unified nomenclature for the highly pathogenic H5N1 avian influenza viruses: divergence of clade 2.2 viruses. Influenza Other Respir Viruses 3, 59-62.
50. WHO/OIE/FAO (2012). Continued evolution of highly pathogenic avian influenza A (H5N1): Updated nomenclature. Influenza Other Respir Viruses 6, 1-5.
51. Wiley, D. C., Wilson, I. A. & Skehel, J. J. (1981). Structural identification of the antibody-binding sites of Hong Kong influenza haemagglutinin and their involvement in antigenic variation. Nature 289, 373-378.
52. Wilson, I. A. & Cox, N. J. (1990). Structural basis of immune recognition of influenza virus hemagglutinin. Annu Rev Immunol 8, 737-771.